Home
Live Updates
CN Bio raises $21 million USD in first close of Series B investment round : vimarsana.com
CN Bio raises $21 million USD in first close of Series B investment round
Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10 M and $5.5 M, respectively. Investment will expand product development and scaling of the organization to meet increased demand for Organ-on-a-Chip (OOC) solutions.
Related Keywords
United Kingdom ,
,
Cn Innovations Holdings Ltd ,
Holdings Ltd ,
Image Credit ,
Bayland Capital ,
Paul Brooks ,
Biopharmaceutical ,
Chip ,
Ompound ,
Rug Discovery ,
Fficacy ,
Iver ,
Iver Disease ,
Echnology ,
Oxicology ,
vimarsana.com © 2020. All Rights Reserved.